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Oral Quercetin Supplementation 
and Blood Oxidative Capacity in Response 
to Ultramarathon Competition
John C. Quindry, Steven R. McAnulty, Matthew B. Hudson, 
Peter Hosick, Charles Dumke, Lisa S. McAnulty, Dru Henson, 
Jason D. Morrow, and David Nieman
Previous research indicates that ultramarathon exercise can result in blood oxidative 
stress. The purpose of this investigation was to examine the efficacy of oral supple-
mentation with quercetin, a naturally occurring compound with known antioxidant 
properties, as a potential countermeasure against blood oxidative stress during an 
ultramarathon competition. In double-blind fashion, 63 participants received either 
oral quercetin (250 mg, 4/day; 1,000 mg/day total) or quercetin-free supplements 
3 weeks before and during the 160-km Western States Endurance Run. Blood drawn 
before and immediately after (quercetin finishers n = 18, quercetin-free finishers 
n = 21) the event was analyzed for changes in blood redox status and oxidative 
damage. Results show that quercetin supplementation did not affect race performance. 
In response to the ultramarathon challenge, aqueous-phase antioxidant capacity 
(ferric-reducing ability of plasma) was similarly elevated in athletes in both quercetin 
and quercetin-free treatments and likely reflects significant increases in plasma urate 
levels. Alternatively, trolox-equivalent antioxidant capacity was not altered by exer-
cise or quercetin. Accordingly, neither F2-isoprostances nor protein carbonyls were 
influenced by either exercise or quercetin supplementation. In the absence of postrace 
blood oxidative damage, these findings suggest that oral quercetin supplementation 
does not alter blood plasma lipid or aqueous-phase antioxidant capacity or oxidative 
damage during an ultramarathon challenge.
Keywords: antioxidant, endurance exercise, flavonol
Acute physical activity is generally marked by an identifiable oxidative stress 
in the blood plasma (Powers, DeRuisseau, Quindry, & Hamilton, 2004). This oxi-
dative stress is often accompanied by acute changes in blood redox status, which, 
to some extent, are thought to reflect alterations in muscle redox status. Subtle 
redox perturbations in response to acute physical activity, moreover, are held to be 
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beneficial. Indeed, the acute oxidative stress incurred during exercise of moderate 
intensity and duration promotes some of the beneficial adaptations to exercise 
training (Gomez-Cabrera et al., 2005; Ji, Gomez-Cabrera, & Vina, 2006; Powers, 
Ji, & Leeuwenburgh, 1999). In contrast, severe or prolonged redox fluctuations as 
experienced during ultramarathon events are often considered deleterious to ath-
letes’ health and performance (Powers et al., 2004), although a direct cause-and-
effect relationship is difficult to establish. In support, recent investigations of the 
blood oxidative-stress response to ultraendurance exercise have demonstrated 
elevations in various markers for oxidative damage (Liu et al., 1999; Nieman et 
al., 2003, 2004). These findings suggest an associative link between oxidative 
stress and fatigue experienced during ultramarathon participation. Accordingly, 
research efforts should be made to seek efficacious antioxidant countertherapies 
against the oxidative stress induced by prolonged exercise. Recent efforts have 
focused on the antioxidant properties of flavonols, molecules found abundantly in 
well-rounded diets including whole foods (Erdman et al., 2007; Manach, William-
son, Morand, Scalbert, & Remesy, 2005). It is largely unknown whether supple-
mentation with flavonol compounds in the existing diets of ultraendurance ath-
letes would prove beneficial to health and performance.
Recent evidence demonstrates the role flavonols play in preventing degenera-
tive processes through anti-inflammatory, cardioprotective, anticarcinogenic, and 
antioxidant activities (Erdman et al., 2007; Manach et al., 2005). Quercetin ranks 
high among flavonols thought to promote good health through antioxidant capabili-
ties (Silva et al., 2002). The current interest in quercetin is founded by its high 
degree of bioactivity and because it is highly concentrated in whole foods associ-
ated with good health: onions, apples, berries, red wine, broccoli, and tea (Erdman 
et al.; Manach et al.). Early studies indicate that quercetin has measurable effects on 
plasma antioxidant and oxidation biomarkers (Filipe et al., 2001; Hou, Zhou, Yang, 
& Liu, 2004). Furthermore, MacRae and Mefferd (2006) attributed improvements 
in cycle performance to the antioxidant properties of a quercetin-containing supple-
ment. In support, quercetin has been shown to possess potent antioxidant properties 
through a variety of reactive sites primarily associated with two hydroxyl groups 
found on the catachol-type B-ring (Rice-Evans & Miller, 1996). Previous work by 
Quercegen Pharma indicates that quercetin potency is enhanced by cosupplementa-
tion with both vitamin C and niacin (Lines, 2006). Accordingly, there is reason to 
suspect that quercetin supplementation might fortify antioxidants in the aqueous 
phase of blood plasma. Further benefits might be conferred by preventing eleva-
tions in the inflammatory mediators COX-2 and NF-B in the presence of quercetin 
(Garcia-Mediavilla et al., 2007; Martinez-Florez, Gutierrez-Fernandez, Sanchez-
Campos, Gonzalez-Gallego, & Tunon, 2005). We have previously shown that quer-
cetin supplementation reduced the incidence of upper respiratory tract infection in 
the weeks after 3 days of intensive cardiovascular exercise (Nieman et al., 2007). 
Whether the antioxidant and anti-inflammatory properties of quercetin are mecha-
nistically linked, perhaps through redox perturbation, is currently unknown.
Based on these previous works demonstrating the antioxidant potential of 
quercetin, we conducted the current investigation to test whether oral quercetin 
supplementation would prove beneficial against the blood oxidative stress incurred 
during an ultramarathon foot race. Specifically, we chose to test the effects of a 
1,000-mg daily quercetin dose on exercise-induced oxidative stress in the 160-km 
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Western States Endurance Race (WSER). This dosage was chosen to achieve 
plasma quercetin levels similar to those in previous, unpublished in vitro studies 
in which laboratory mice ingested plasma quercetin dosed to 12 mg/kg body 
weight (personal communication, J. Mark Davis, University of South Carolina, 
November 2005). The WSER is an annual ultramarathon held in the Sierra Nevada 
mountain range and is widely regarded as one of the most challenging events of 
its type. Furthermore, we have previously observed elevations in blood oxidative 
stress in participants after running in the WSER (McAnulty et al., 2007; Nieman 
et al., 2003). Accordingly, we hypothesized that participation in the WSER ultra-
marathon would elevate blood markers of oxidative stress. We further hypothe-
sized that quercetin supplementation would attenuate the oxidative stress associ-
ated with ultramarathon participation.
Methods
Participant Recruitment and Race Description
To investigate the oxidative-stress response to ultraendurance physical activity 
we sampled participants in the 160-km WSER, a point-to-point trail run. Held in 
the Sierra Nevada Mountains of northern California, the WSER is regarded as 
one of the most arduous organized running events in the United States. Beginning 
in Squaw Valley, CA (1,890 m altitude), and concluding in Auburn, CA (366 m), 
race finishers experience a total altitude gain and loss of 5,500 m and 6,700 m, 
respectively. After a 5 a.m. race start, runners must reach the finish line within 
30 hr to be eligible for an official finish time. Sixty-three participants (15 women, 
48 men) were recruited for this investigation from the registered entrants of the 
2006 WSER field, and written informed consent was obtained. The study 
informed-consent document was approved by the Appalachian State University 
Institutional Review Board in addition to the Western States Endurance Run 
Medical Research Board.
Research Design
Supplementation. After recruitment, participants were placed in either querce-
tin or quercetin-free treatments using a randomized double-blind assignment. Par-
ticipants ingested soft chews with or without 1,000 mg/day quercetin under 
double-blinded procedures for 3 weeks before and the morning of the WSER 
(Figure 1). Specifically, participants ingested four individually wrapped chews 
each day (two before breakfast and two before dinner). Chews also contained 
250 mg pure quercetin, 250 mg vitamin C, 20 mg niacin, and 20 kcal of sugars in 
a carnauba wax and soy lecithin base colored with FD&C yellow #6 (Nutravail 
Technologies Inc., Chantilly, VA, and Quercegen Pharma, Newton, MA). 
Quercetin-free supplements were prepared identically minus the quercetin, vita-
min C, and niacin to control for researcher or participant bias. Previous data from 
Quercegen Pharma indicate that vitamin C and niacin are necessary to enhance 
quercetin bioavailability. Thus this study tested whether quercetin-containing 
chews that included vitamin C and niacin had an influence on plasma oxidative 
stress and time to race completion.
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On race day, participants ingested all four chews before the 5 a.m. start 
time. During the supplementation period, they were instructed to ingest their 
normal diet of food, beverages, and supplements. By maintaining their dietary-
intake routines during supplementation, participants avoided additional nonsup-
plementation quercetin intake. A 3-day food record was obtained during the 
3-week prerace supplementation period. That is, participants were instructed to 
record their food intakes during days randomly assigned for the supplementation 
period. Food records were analyzed using the computerized nutrition software 
program Food Processor (ESHA Research, Salem, OR). Food records did not 
include the supplements provided to quercetin and quercetin-free groups. In 
regard to vitamin C concentrations, however, both quercetin and quercetin-free 
participants received equal amounts of vitamin C from their chews.
Blood Collection, Body Mass, and Questionnaires. Blood samples were drawn 
during registration in Squaw Valley, CA, the morning before the race and 
15–30 min postrace in Auburn, CA. They were drawn from the antecubital vein 
with participants in the supine position. Plasma aliquots were immediately 
obtained, frozen, and maintained at –80 °C until biochemical analysis. In addi-
tion, a frozen aliquot of plasma was sent to a clinical laboratory for a comprehen-
sive diagnostic chemistry panel, including uric acid, using an LX-20 clinical ana-
lyzer (Beckman, Brea, CA). During race registration, body mass was measured, 
and participants completed a questionnaire designed to survey basic demograph-
ics and training history. On race day, body mass was measured at the 90-km aid 
station (Michigan Bluff, 1,220 m) and within 5–15 min postrace at Auburn, CA. 
Participants completed a postrace questionnaire indicating adherence to the 
research design. They consumed food and beverages ad libitum during the race.
Plasma Quercetin
Total plasma quercetin (quercetin and its primary conjugates) was measured after 
solid-phase extraction via reverse-phase high-performance liquid chromato graphy 
(HPLC) with UV detection as described by Quercegen Pharma (Newton, MA, 
personal communication). This procedure is similar to that previously published 
by Ishii, Furuta, and Kasuya (2003). Quercetin conjugates were hydrolyzed by 
incubating 250- to 500-l plasma aliquots with 10 µl of 10% DL-dithiothreitol 
(DTT) solution, 50 µl of 0.58-M acetic acid, a 50-µl mixture of -glucuronidase 
and arylsulfatase, and crude extract from Helix pomatia (Roche Diagnostics 
GmbH, Mannheim, Germany). After incubation, 500 µl of 0.01-M oxalic acid was 
Figure 1 — Study supplementation and sample-collection timeline.
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added and mixed, samples were centrifuged, and supernatants were applied to 
solid-phase extraction cartridges (Oasis HLB 1-cc [30-mg] SEP cartridge; Waters 
Corp., Milford, MA). Eluant was collected and placed in a vacuum concentrator 
(Savant Speed Vac SC 110, Savant Instruments Inc., Farmingdale, NY). Residue 
was reconstituted with methanol for HPLC analysis using a Waters Breeze system 
(Waters Corp.) consisting of a Waters 1525 binary HPLC pump, 2487 UV detec-
tor, and Symmetry C18 5-m 4.6  150-mm column. Prepared samples of 100-µl 
final volumes were loaded into the HPLC device with a mobile phase of ace-
tonitrile (0.1% HCOOH) H2O (0.1% HCOOH) at a flow rate of 1 ml/min. Data 
were acquired and processed using Breeze software (ver. 3.02). Quantification of 
the quercetin peak was based on the standard controls. Standards and samples 
were treated identically.
Plasma Oxidative Stress and Antioxidant Biomarkers
Ferric-Reducing Antioxidant Potential. Total plasma antioxidant potential was 
determined by the ferric-reducing ability of plasma (FRAP) assay according to 
the methodology of Benzie and Strain (1996). This assay utilizes water-soluble 
antioxidants native to the plasma to reduce ferric iron to the ferrous form, subse-
quently producing a spectrophotometrically identifiable chromogen. Samples and 
standards were expressed as ascorbate equivalents based on a physiologic ascor-
bate standard curve. Intra-assay and interassay coefficients of variation were less 
than 5% and 7%, respectively.
Trolox-Equivalent Antioxidant Capacity. Antioxidant activity was determined 
in EDTA-treated plasma samples using the trolox-equivalent antioxidant-capacity 
(TEAC) method as described by Cao and Prior (1998). Briefly, a free-radical- 
producing enzymatic system was created using horseradish peroxidase enzyme 
and 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid), hydrogen peroxide, 
and peroxidase. The free-radical-quenching capacity of plasma samples added 
to this free-radical-generating reaction was assessed spectrophotometrically, 
quantified, and expressed as trolox equivalents. Intra-assay and interassay coef-
ficients of variation were less than 3% and 4%, respectively.
F2-Isoprostanes. Plasma F2-isoprostanes were determined using gas- 
chromatography mass spectrometry (GC-MS) according to the methodology of 
Morrow and Roberts (1999). Briefly, free F2-isoprostanes were extracted from 
500 µl plasma added to a deuterated [2H4] PGF2 internal standard. The mixture 
was then added to a C18 SEP Pak column, followed by silica solid-phase extrac-
tions. F2-isoprostanes were converted to pentafluorobenzyl esters, subjected to 
thin-layer chromatography, and converted to trimethylsilyl ether derivatives. Sam-
ples were analyzed by negative-ion chemical-ionization GC-MS using a Nermag 
R10-10C mass spectrometer interfaced with an Agilent computer system.
Protein Carbonyls. Protein carbonyls, a measure of protein oxidation, were 
analyzed using a commercially available ELISA kit (Zentech Technology, distrib-
uted by Northwest Life Science Specialties, Vancouver, WA). Before analysis all 
plasma samples were assayed for protein concentration based on the methods of 
Bradford (1976) and adjusted to 4 mg/ml protein using phosphate-buffered saline 
before assay using a phosphate buffer (Bradford).
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Statistical Analysis
Participant descriptive data were compared between groups using Student’s t tests. 
Blood-variable data were analyzed using a 2 (groups)  2 (time points) repeated-
measures ANOVA and expressed as M ± SE. When the interaction effect was 
significant (p ≤ .05), pre- to postrace changes were calculated and compared 
between quercetin and quercetin-free groups using a Tukey’s post hoc test, with 
significance set at p ≤ .05. All statistical analyses were accomplished using Instat 
version 1.01 (San Diego, CA) and SPSS version 13.0 (Chicago).
Results
Participant Characteristics and Race Performance
Air temperature was 22 °C at the 5 a.m. race start (Squaw Valley, CA) and increased 
to 38 °C by 2 p.m. (Michigan Bluff), 27 °C by 12 a.m. (approximate time of the 
overall race winner, Auburn, CA), and 31 °C by 11 a.m. (30-hr official finish time 
limit). The humidity ranged from 25% to 58% during the last half of the race.
Participant characteristics for quercetin and quercetin-free groups are presented 
in Table 1. Thirty-nine of 63 participants (n = 18 for quercetin, n = 21 for quercetin-
free) completed the 160-km race event and adhered fully to the study design. Notably, 
the attrition rate, approximately 35% for both treatments, was typical for this event.
Data indicate no significant differences in age, training volume, racing his-
tory, race time, and body weight pre-, during, and postevent for the two groups. 
Moreover, male (n = 32) and female (n = 7) runners did not differ significantly in 
race finish time (27.0 ± 0.5 vs. 27.0 ± 1.4 hr, respectively, p = .992) or any of the 
other measured variables save body mass and composition. Thus male and female 
competitors’ data were combined for these analyses. Plasma volume did not 
change appreciably and did not differ significantly between groups (–0.3% ± 0.5% 
and –0.3% ± 0.4%, respectively, p = .928). Taken in combination with body-mass 
data (Table 1), which was maintained near prerace levels for both groups, partici-
pants maintained an adequate hydration level during the race.
Table 1 Participant Characteristics
Quercetin  
(n = 18)
Quercetin-free  
(n = 22) p
Age (years) 44.2 ± 2.0 46.0 ± 2.3 .575
Years of running 13.0 ± 2.3 13.3 ± 1.7 .780
Ultras raced 39.6 ± 10.6 37.9 ± 6.0 .988
Training (miles/week) 51.8 ± 3.1 47.1 ± 4.4 .398
Race time (hr) 26.4 ± 0.7 27.5 ± 0.6 .237
Weight prerace (lb) 152 ± 6 163 ± 5 .168
Weight at 55 miles (lb) 152 ± 5 162 ± 5 .169
Weight postrace (lb) 150 ± 5 161 ± 5 .140
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Plasma Quercetin and Dietary Recall
After 3 weeks supplementation, plasma quercetin levels were 6.6-fold higher in 
the quercetin group than in the quercetin-free group and 3.1-fold higher postrace 
(interaction effect, p < .001; Figure 2). Note that both treatment groups experi-
enced a significant pre- to postrace drop in plasma quercetin, although the magni-
tude of quercetin loss was greatest in the quercetin-supplemented participants. A 
poststudy questionnaire revealed that the double-blind methods used in the study 
were successful in that 22% of the quercetin-supplemented participants indicated 
they believed they had consumed quercetin, 17% thought they were quercetin 
free, and 61% were unsure of their supplement status. Of the participants receiv-
ing no quercetin, 38% suspected quercetin, 29% thought they were quercetin free, 
and 33% were uncertain of their treatment.
Three-day food records before the race indicated no significant differences in 
macronutrient intakes between groups, with a mean energy intake for all partici-
pants combined of 11.0 ± 0.8 MJ/day (2,620 ± 184 kcal/day) and percent of energy 
intakes of 51.1% ± 2.3% carbohydrate, 31.5% ± 1.8% fat, and 18.0% ± 1.2% pro-
tein. In addition, food-record analysis revealed no significant differences in the 
intakes of the antioxidants vitamin E (quercetin-free = 28.0 ± 10.2 mg, quercetin = 
34.2 ± 14.7 mg; p = .728), vitamin A (quercetin-free = 772.2 ± 109.0 IU, quercetin 
= 780.1 ± 160.4 IU; p = .968), vitamin C (quercetin-free = 353.5 ± 143.5 mg, 
quercetin = 224.4 ± 51.8 mg; p = .413), or selenium (quercetin-free = 113.8 ± 
21.7 g, quercetin = 111.1 ± 19.0 g; p = .926).
Figure 2 — Plasma quercetin values pre- and postrace, M ± SEM. *Significantly different 
from quercetin-free, p ≤ .05. #Time effect, p ≤ .01.
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Biomarkers of Plasma Antioxidant Status
As compared with baseline values, plasma FRAP increased significantly after the 
ultramarathon (Figure 3[a]). This finding was independent of quercetin supple-
mentation. Similarly, a significant pre- to postrace rise in plasma uric acid was 
observed (Figure 3[b]). Notably, the pre- to postrace changes (%) in FRAP and 
uric acid were calculated and found to correlate for both the quercetin-free 
(r = .693, p = .001) and quercetin-supplemented (r = .621, p = .005) groups 
(Figure 4). In contrast, TEAC was not altered by either the ultramarathon partici-
pation or quercetin supplementation (Figure 5).
Figure 3 — (a) Ferric-reducing ability of plasma pre- and postrace, M ± SEM. #Significant 
time effect, p ≤ .05. (b) Plasma uric acid values pre- and postrace, M ± SEM. #Significant 
time effect, p ≤ .05.
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Biomarkers of Plasma Oxidative Damage
Despite the apparent trends, neither quercetin nor race participation elicited a 
change in plasma F2-isoprostane values (Figure 6[a]). Similarly, plasma protein 
carbonyls were unaffected by either the quercetin treatment or the race event 
(Figure 6[b]).
Figure 4 — Pre- to postexercise % change in ferric-reducing ability of plasma (FRAP) 
and % change in plasma urate.
Figure 5 — Plasma trolox-equivalent antioxidant capacity pre- and postrace, M ± SEM.
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Discussion
Oxidative stress is a well-defined outcome of acute physical activity (Powers et 
al., 1999). Many recent investigations of exercising humans have used blood 
markers of oxidative stress because of the minimally invasive nature of phlebot-
omy relative to muscle biopsy. Using currently available biomarkers, however, 
identification of blood oxidative stress after exercise often requires participants to 
perform either high-intensity or long-duration exercise (Nieman et al., 2003; Quin-
dry, Stone, King, & Broeder, 2003). Although these redox perturbations are thought 
to be a necessary part of the stimulus-adaptation response to exercise training, the 
Figure 6 — (a) Plasma F2-isoprostane values pre- and postrace, M ± SEM. (b) Plasma 
protein carbonyl values pre- and postrace, M ± SEM.
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oxidative-stress response to prolonged ultraendurance-type exercise is held by 
some to be detrimental to athlete health and training status (Powers et al., 2004), 
although these effects have been difficult to quantify. In support, the thriving 
antioxidant-supplement business is a testament to the belief of some athletes and 
scientists that the oxidative stress associated with ultramarathon exercise is counter-
productive to the aims of exercise training. Accordingly, ongoing research is aimed 
at uncovering interventions to counter the exercise-induced oxidative stress of 
ultraendurance exercise with the intent of improved athlete performance or health 
during the postcompetition recovery. This rationale led to the current investigation 
of supplementation with quercetin, a naturally occurring flavonol compound known 
to have powerful antioxidant properties (Silva et al., 2002). Specifically, a com-
bined daily dose of 1,000 mg quercetin (which also included niacin and the power-
ful antioxidant vitamin C) was investigated as an antioxidant countertherapy in 
athletes competing in the WSER 160-km trail race. The addition of vitamin C and 
niacin to the quercetin supplement was intended to potentiate the bioavailability of 
quercetin (Lines, 2006). The WSER is widely held to be among the most demand-
ing ultramarathon foot races in the United States and, as demonstrated previously, 
is a prime venue for an oxidative-stress field study (McAnulty et al., 2007; Nieman 
et al., 2003). Contrary to our hypotheses, findings from this investigation do not 
support the contention that a combined quercetin, niacin, and vitamin C supple-
ment fortifies plasma antioxidant levels against ultramarathon-induced oxidative 
stress in blood plasma. In respect to ergogenics and performance, this finding is 
supported by the fact that quercetin-supplemented participants did not perform 
better than participants receiving quercetin-free supplements.
Quercetin and Blood Plasma Antioxidant Fortification
In a mixed biological solution such as human plasma, a classic approach to the 
study of oxidative stress incorporates measures of both taxation of antioxidant 
defenses and the generation of oxidative-damage products (Buettner, 1993). 
Accordingly, multiple redox-sensitive bioassays were used to test the antioxidant 
potential of oral quercetin supplementation on plasma redox status both before 
and after an ultramarathon. Supporting the rationale that quercetin supplementa-
tion would fortify the aqueous antioxidant defenses in plasma, several investiga-
tions have demonstrated that the presence of quercetin and quercetin metabolites 
in human plasma effectively prevented copper-catalyzed LDL peroxidation (Filipe 
et al., 2001; Hou et al., 2004). MacRae and Mefferd (2006) examined a quercetin-
containing compound in athletes performing cycling time trials. In contrast to the 
current study, their results demonstrated modest but significant improvements in 
power output in quercetin-supplemented participants. Although not formally 
tested, this outcome was attributed to the antioxidant properties of quercetin. As 
an additional consideration, MacRae and Mefferd’s investigation examined a 
mixed supplement that included 150 mg vitamin C and 300 mg of green tea, 
B vitamins, and quercetin. As with the current investigation, discerning the indi-
vidual effects of quercetin from the potential synergistic effects with the other 
compounds examined by MacRae and Mefferd requires further study. In addition, 
the current study design of ultramarathon competition in extreme conditions 
varied considerably from that of MacRae and Mefferd’s investigation. Thus, it is 
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plausible that the quercetin efficacy observed previously might have been masked 
by the physical demands of the WSER trial in the current investigation.
For the current investigation, daily quercetin doses of 1,000 mg elicited a 
mean rise in plasma quercetin of more than 600% as compared with quercetin-
free participants. Based on preliminary work in our laboratory, this concentration 
was chosen to produce a plasma quercetin similar to concentrations from previous 
in vitro investigations. In this investigation, however, elevated prerace quercetin 
levels did not produce elevations in plasma antioxidant capacity as measured by 
FRAP and TEAC biomarkers. Indeed, this finding casts significant doubt on the 
ability of quercetin supplementation to significantly alter aqueous-phase antioxi-
dant capacity, at least to the available limits of biomarker sensitivity. During the 
course of the ultramarathon competition, moreover, plasma quercetin levels 
decreased significantly in both quercetin-free and quercetin groups, although 
quercetin levels remained significantly higher in the supplemented participants. 
Similar to prerace findings in supplemented participants, elevated quercetin levels 
in the postrace plasma did not influence plasma FRAP or TEAC values. In fact, 
mean FRAP values increased significantly from pre- to postrace in both quercetin-
supplemented and quercetin-free participants. A postultramarathon rise in plasma 
FRAP values has been identified previously (Nieman et al., 2003). Much of this 
rise is thought to result from elevations in concentrations of plasma uric acid, the 
most significant contributor to aqueous-phase plasma antioxidant capacity 
(Wayner, Burton, Ingold, Barclay, & Locke, 1987). Indeed, there were significant 
positive correlations between the pre- and postrace percent increase in plasma 
FRAP and uric acid in both treatment groups. Biochemically, elevated plasma uric 
acid as a result of acute exercise is the direct result of accelerated purine metabo-
lism in skeletal muscle, in which two molecules of superoxide are created for each 
uric acid molecule produced (Liu et al., 1999). The import of this phenomenon 
hinges on the fact that production of each additional uric acid molecule also yields 
two molecules of the free radical superoxide (Halliwell & Gutteridge, 1999). In 
this respect, the fact that both quercetin-free and quercetin-treated participants 
experienced a similar mean rise in plasma uric acid suggests that both groups 
experienced similar free-radical load during the ultramarathon. Finally, the rise in 
plasma FRAP resulting from both quercetin-containing and quercetin-free sup-
plements could be attributed to alterations in plasma vitamin C caused by supple-
mentation or physical exertion. This point is particularly important with respect to 
the current investigation, in which both quercetin-containing and non-quercetin-
containing chews included vitamin C.
Oxidative Damage After the 2006 WSER Ultramarathon
The second aspect of the “free-radical pecking order” described previously 
(Buettner, 1993) involves oxidative-damage products. Previous work by our 
group at the WSER (2003) has demonstrated that this ultramarathon yielded 
significant elevations in the lipid oxidative-damage markers F2-isoprostanes 
(Nieman et al., 2003). Specifically, when compared with prerace values, the rise 
in F2-isoprostanes was most marked at midrace but remained elevated postrace 
(Nieman et al., 2003). Similarly, Nieman et al. (2004) have found comparable 
elevations in plasma oxidative-damage markers after the Ironman Triathlon. In 
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contrast to those previous investigations, we did not observe a rise in either 
plasma F2-isoprostanes or protein carbonyl concentrations. A previous oxidative-
stress study conducted during the 2005 WSER also found that athletes (no treat-
ment) did not exhibit a mean rise in plasma F2-isoprostanes (McAnulty et al., 
2007). Similar to F2-isoprostanes, plasma protein carbonyls in the current study 
were not elevated after the ultramarathon in either treatment group. Accord-
ingly, because plasma oxidative-damage markers were not elevated by ultra-
marathon competition, our evaluation of quercetin efficacy as a supplemental 
antioxidant rests on the measures of plasma redox status (FRAP and TEAC). As 
discussed previously quercetin did not affect plasma FRAP or TEAC levels, 
indicating that quercetin does not alter the aqueous antioxidant capacity to mea-
surable levels.
The finding that plasma oxidative-damage biomarkers were not elevated in 
athletes competing in the 2006 WSER ultramarathon is interesting and worthy of 
further discussion. First, in an effort to maximize our ability to identify plasma 
oxidative damage and identify the antioxidant potential of quercetin supplementa-
tion, we chose to employ two of the most sensitive biomarkers for oxidative stress, 
F2-isoprostanes and protein carbonyls. The F2-isoprostane biomarker, as assayed 
by GC-MS, is the gold standard for lipid peroxidation damage (Morrow & Rob-
erts, 1999). In addition to the sensitivity of the GC-MS technique, the primary 
advantage to the measure of F2-isoprostanes is that they are more stable than other 
lipid oxidative-damage products (Dotan, Lichtenberg, & Pinchuk, 2004). In this 
investigation, postrace blood was drawn immediately after medical confirmation 
of athlete vital status. As with our previous investigations, we employed a rapid 
and meticulous sample-handling protocol to minimize in vitro loss of identifiable 
oxidative-damage products. Finally, to account for the potential conversion of F2-
isoprostanes to other oxidative-damage products through subsequent free-radical 
chain reactions (Dotan et al.), protein carbonyls were measured using antibody 
technology. Agreement between F2-isoprostane and protein carbonyl data might 
suggest that, within the current constraints of oxidative-damage-marker sensitiv-
ity, a Type II error was avoided with respect to oxidative damage after the ultra-
marathon. We concede, however, that blood oxidative-stress assessment in field-
type studies can be difficult. Accordingly, we chose a variety of the most sensitive 
oxidative-stress biomarkers with the intent that positive findings could be con-
firmed by multiple markers. In future studies, experimental-design construction 
would benefit from including midrace blood sampling to more clearly identify 
blood oxidative-damage responses of a transient nature.
As an alternative explanation for the observation that blood oxidative-dam-
age markers did not rise, the 2006 WSER was exceedingly hot compared with 
preceding years, resulting in finish times several hours slower than average. 
Accordingly, finish times likely reflect athlete caution as much as an outcome of 
hyperthermic exercise. If correct, this hypothesis could explain year-to-year vari-
ation in oxidative damage (McAnulty et al., 2007; Nieman et al., 2003). Alterna-
tively, both quercetin-containing and quercetin-free supplements contained the 
potent water-soluble antioxidant vitamin C. Based on previous findings, there is 
good cause to suspect that the presence of vitamin C in both experimental treat-
ments of the current investigation could have masked the oxidative-stress response 
observed in previous years (Goldfarb, Patrick, Bryer, & You, 2005; McAnulty et 
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al.; Nieman et al., 2003). Other explanations for year-to-year discrepancies in the 
oxidative-damage response to the ultramarathon race might include participant 
nutrient  intakes during the event. That is, ultramarathon athletes can be quite 
varied in their preferred caloric and nutrient intakes during competition. Previous 
works have demonstrated that caloric intake during exercise attenuates blood oxi-
dative damage (Burneiko et al., 2006). In this investigation, participants were 
allowed to replenish energy stores ad libitum. Individual nutrition can vary sig-
nificantly in both quantity and content. The potential impact of individual vari-
ability in food volume and antioxidant content on oxidative-damage markers 
cannot be discounted and is a study limitation. In addition, the transient nature of 
oxidative stress and its associated biomarkers can make identifying oxidative 
stress difficult, given the competition logistics of the WSER, in which blood-
sampling opportunities are limited. Nonetheless, more frequent blood sampling 
throughout the event might have enabled us to identify a midrace spike in F2-
isoprostanes and protein carbonyls not apparent in the posttesting of the current 
investigation.
Conclusions
This investigation examined daily quercetin supplementation as a preventive aid 
against plasma oxidative stress incurred during an ultramarathon competition. 
Based on the free-radical pecking-order theory of biological solutions (Buettner, 
1993), the efficacy of elevated quercetin against exercise-induced oxidative stress 
in blood plasma would manifest first as an elevation in plasma antioxidant capac-
ity. The lack of oxidative-damage products after the ultramarathon indicates that 
an effect of this sort was not observed in our participants. Thus, at this time it does 
not appear that oral quercetin supplementation protects against the plasma oxida-
tive stress induced by ultramarathon exercise, although this conclusion cannot be 
confirmed without further examination in which oxidative damage is clearly pro-
duced by the exercise challenge. Another plausible consideration of the current 
findings is that the conjugated quercetin metabolites do not exhibit antioxidant 
activities detectable within the confines of the antioxidant assays we employed 
(FRAP and TEAC). Therefore it does not appear that oral quercetin supplements 
protect against oxidative stress induced by ultramarathon exercise, but this con-
clusion cannot be confirmed without further examination whereby oxidative 
damage is clearly produced by the exercise challenge. Future investigations might 
uncover heretofore-unknown mechanisms of protection by quercetin or quercetin 
metabolites in exercise-stress scenarios.
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